5-iodo-6-amino-1,2-benzopyrone has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haskó, G; Kun, E; Mabley, JG; Rabinovitch, A; Salzman, AL; Suarez-Pinzon, WL; Szabó, C | 1 |
1 other study(ies) available for 5-iodo-6-amino-1,2-benzopyrone and Alloxan Diabetes
| Article | Year |
|---|---|
Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
Topics: Animals; Apoptosis; Blood Glucose; Cell Survival; Coumarins; Cytokines; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Genotype; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mutation; Nitrates; Nitric Oxide; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Severity of Illness Index; Streptozocin; Tumor Cells, Cultured | 2001 |